课题基金 / 基金详情

High-throughput screening for small molecules demonstrating toxicity against human neuroendocrine tumor cell lines

High-throughput screening for small molecules demonstrating toxicity against human neuroendocrine tumor cell lines
高通量筛选对人类神经内分泌肿瘤细胞系具有毒性的小分子
批准号：
10005001
负责人：
Matthew Hall
金额：
$13.27万
依托单位：
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/10005001
关键词：
AffectCancer cell lineCell LineClinicalHumanIncidenceLibrariesLung NeoplasmsLung Neuroendocrine NeoplasmMalignant NeoplasmsMalignant neoplasm of lungNeuroendocrine CellNeuroendocrine TumorsNuclear Pore ComplexPharmaceutical PreparationsReportingSubgroupToxic effectTumor Cell LineUnited Statescancer typeeffective therapyhigh throughput screeningscreeningsmall moleculesmall molecule librariestumor

项目摘要

项目成果

Matthew Hall的其他基金

相似基金

相关文献

中文摘要
翻译
肺NETs包括由神经内分泌细胞引起的异质性恶性肿瘤亚组。NET按其分级可分为4个亚型。在美国，肺NETs的年发病率在过去30年中大幅增加，这表明对这类肿瘤有效治疗的需求日益增加。
英文摘要
Lung NETs comprise a heterogeneous subgroup of malignancies that arise from neuroendocrine cells. NET can be classified into four subtypes according to their differentiation of grade. In the United States, the annual incidence of lung NETs has substantially increased over the past 30 years, highlighting an increased need for an effective therapy against this type of tumors. During this reporting period, the project team selected and screened several lung NET lines against more than 4,000 compounds in the NPC and MIPE libraries. Active compounds were cherry-picked for expanded toxicity screening against a larger panel of cancer cell lines, and those hits with attractive activity profiles are currently undergoing advanced characterization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BRD4 Inhibitors as Potential Therapeutics for Oncology
qHTS to Identify Inhibitors of Mutant and Wildtype NSD2
qHTS to Identify Activators and Inhibitors of Wip1
qHTS to Identify Inducers of Oligodendrocyte-precursor cell (OPC) Remyelination
海外基金